ARID1A and cancer: While SMARCB1 mutations cause malignant rhabdoid tumors and epithelioid sarcoma, the dysfunction of ARID1A predisposes one to a wide variety of cancers, including ovarian clear cell carcinoma, endometrioid carcinoma, neuroblastoma, and bladder cancer.